Stockscreener 앱 받기
1.485
0.34%
-0.005
전일 마감가:
$1.49
열려 있는:
$1.48
하루 거래량:
122.94K
Relative Volume:
0.04
시가총액:
$62.19M
수익:
-
순이익/손실:
$-11.24M
주가수익비율:
-1.9501
EPS:
-0.7615
순현금흐름:
$-4.79M
1주 성능:
+3.13%
1개월 성능:
+7.61%
6개월 성능:
+22.73%
1년 성능:
+32.59%
1일 변동 폭
$1.445
$1.52
1주일 범위
$1.4144
$1.53
52주 변동 폭
$0.73
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
명칭
Mira Pharmaceuticals Inc
전화
813-369-5150
주소
1200 BRICKELL AVENUE, MIAMI
MIRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.485 | 62.40M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
1,057.64 | 919.64B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
214.19 | 509.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
226.76 | 394.69B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
134.36 | 254.37B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
98.97 | 248.95B | 63.90B | 19.05B | 13.05B | 7.5596 |
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - Daytona Beach News-Journal
MIRA Pharmaceuticals expands stock offering by $15M - MSN
Mira Pharmaceuticals increases at-the-market offering by $15.2 million - Investing.com Canada
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
MIRA Pharmaceuticals Expands Stock Offering by $15M - TipRanks
MIRA Pharmaceuticals Increases Stock Offering Limit - TradingView — Track All Markets
Mira Pharmaceuticals (MIRA) Stock Analysis Report | Financials & Insights - Benzinga
How MIRA Pharmaceuticals Inc. stock performs in rising dollar environmentTrade Ideas & Verified Technical Signals - Newser
Why MIRA Pharmaceuticals Inc. stock is seen as undervaluedJuly 2025 Review & Daily Technical Forecast Reports - Newser
Is MIRA Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Why MIRA Pharmaceuticals Inc. stock remains on watchlistsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
MIRA Pharmaceuticals (NASDAQ:MIRA) and Annovis Bio (NYSE:ANVS) Critical Analysis - Defense World
Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
What risks investors should watch in MIRA Pharmaceuticals Inc. stockQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
Will MIRA Pharmaceuticals Inc. stock see PE expansionProfit Target & Trade Opportunity Analysis - newser.com
What high frequency data says about MIRA Pharmaceuticals Inc.Weekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Why MIRA Pharmaceuticals Inc. stock is favored by pension funds2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Is MIRA Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Will MIRA Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is MIRA Pharmaceuticals Inc. showing signs of accumulationMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Will MIRA Pharmaceuticals Inc. continue its uptrendDip Buying & Smart Allocation Stock Reports - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Will MIRA Pharmaceuticals Inc. stock benefit from sector rotation2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Applying big data sentiment scoring on MIRA Pharmaceuticals Inc.Earnings Miss & Long-Term Growth Stock Strategies - newser.com
What earnings revisions data tells us about MIRA Pharmaceuticals Inc.2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Using R and stats models for MIRA Pharmaceuticals Inc. forecasting2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Is MIRA Pharmaceuticals Inc. forming a bottoming baseLong Setup & Fast Entry and Exit Trade Plans - newser.com
Mira Pharmaceuticals Inc (MIRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.72%
1.91%
자본화:
|
볼륨(24시간):